3.73
price down icon1.84%   -0.07
after-market Handel nachbörslich: 3.73
loading
Schlusskurs vom Vortag:
$3.80
Offen:
$3.81
24-Stunden-Volumen:
172.85K
Relative Volume:
1.23
Marktkapitalisierung:
$195.33M
Einnahmen:
$81.06M
Nettoeinkommen (Verlust:
$-55.55M
KGV:
-3.2719
EPS:
-1.14
Netto-Cashflow:
$-47.98M
1W Leistung:
-7.67%
1M Leistung:
+7.49%
6M Leistung:
+51.01%
1J Leistung:
-41.81%
1-Tages-Spanne:
Value
$3.65
$3.81
1-Wochen-Bereich:
Value
$3.65
$4.08
52-Wochen-Spanne:
Value
$2.03
$7.03

Sight Sciences Inc Stock (SGHT) Company Profile

Name
Firmenname
Sight Sciences Inc
Name
Telefon
(415) 889-0550
Name
Adresse
4040 CAMPBELL AVE,, MENLO PARK
Name
Mitarbeiter
216
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-05
Name
Neueste SEC-Einreichungen
Name
SGHT's Discussions on Twitter

Vergleichen Sie SGHT mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
SGHT
Sight Sciences Inc
3.73 202.66M 81.06M -55.55M -47.98M -1.14
Medical Devices icon
ABT
Abbott Laboratories
132.81 228.80B 43.11B 13.94B 6.78B 7.98
Medical Devices icon
BSX
Boston Scientific Corp
107.29 158.04B 18.49B 2.50B 3.49B 1.68
Medical Devices icon
SYK
Stryker Corp
394.34 149.08B 23.82B 2.92B 4.02B 7.55
Medical Devices icon
MDT
Medtronic Plc
92.85 119.71B 34.20B 4.69B 5.30B 3.63
Medical Devices icon
EW
Edwards Lifesciences Corp
80.96 48.01B 5.69B 1.41B 577.90M 6.95

Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-08-08 Hochstufung Lake Street Hold → Buy
2024-12-06 Eingeleitet UBS Buy
2024-11-04 Herabstufung Lake Street Buy → Hold
2024-08-21 Eingeleitet Lake Street Buy
2023-09-12 Herabstufung BofA Securities Neutral → Underperform
2023-09-12 Herabstufung Piper Sandler Overweight → Neutral
2023-09-12 Herabstufung William Blair Outperform → Mkt Perform
2023-08-24 Herabstufung Morgan Stanley Overweight → Equal-Weight
2023-07-10 Herabstufung Citigroup Buy → Neutral
2023-01-06 Hochstufung Stifel Hold → Buy
2022-10-04 Eingeleitet Needham Hold
2022-07-26 Eingeleitet Stifel Hold
2022-02-03 Eingeleitet William Blair Outperform
2022-01-07 Hochstufung Morgan Stanley Equal-Weight → Overweight
Alle ansehen

Sight Sciences Inc Aktie (SGHT) Neueste Nachrichten

pulisher
Sep 03, 2025

Sight Sciences shares fall 2.84% intraday after TearCare System inclusion in TFOS DEWS III report. - AInvest

Sep 03, 2025
pulisher
Sep 03, 2025

Will Sight Sciences Inc. stock recover after recent dropJuly 2025 Movers & Smart Swing Trading Techniques - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What momentum shifts mean for Sight Sciences Inc.Quarterly Market Summary & Risk Controlled Stock Pick Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Ranking Sight Sciences Inc. among high performing stocks via toolsOptions Play & Verified Momentum Stock Watchlist - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Volume spikes in Sight Sciences Inc. stock – what they meanTrade Risk Report & Low Drawdown Trading Techniques - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

How to escape a deep drawdown in Sight Sciences Inc.Share Buyback & Safe Swing Trade Setups - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Using R and stats models for Sight Sciences Inc. forecastingQuarterly Performance Summary & Accurate Trade Setup Notifications - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Momentum divergence signals in Sight Sciences Inc. chartWeekly Trading Summary & Real-Time Volume Analysis - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What machine learning models say about Sight Sciences Inc.Oil Prices & Fast Exit/Entry Strategy Plans - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

Can momentum traders help lift Sight Sciences Inc.Global Markets & High Conviction Trade Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Is Sight Sciences Inc. benefiting from innovation trendsJuly 2025 Opening Moves & Daily Volume Surge Signals - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Sight Sciences' TearCare System Recognized in Dry Eye Workshop III Report for Clinical Efficacy in Managing Dry Eye Disease - Quiver Quantitative

Sep 02, 2025
pulisher
Sep 02, 2025

Sight Sciences Announces Recognition of the TearCare® - GlobeNewswire

Sep 02, 2025
pulisher
Sep 02, 2025

Major Validation: Sight Sciences TearCare System Added to Gold-Standard TFOS DEWS III Dry Eye Guidelines - Stock Titan

Sep 02, 2025
pulisher
Sep 02, 2025

Will Sight Sciences Inc. stock recover after earningsMarket Rally & Free AI Powered Buy and Sell Recommendations - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Is Sight Sciences Inc. stock ready for a breakoutDollar Strength & Consistent Return Investment Signals - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Top chart patterns to watch in Sight Sciences Inc.July 2025 Recap & AI Enhanced Trading Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

What to do if you’re stuck in Sight Sciences Inc.July 2025 Macro Moves & Free Technical Pattern Based Buy Signals - Newser

Sep 02, 2025
pulisher
Sep 01, 2025

Using data tools to time your Sight Sciences Inc. exitMarket Performance Recap & Smart Swing Trading Alerts - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Measuring Sight Sciences Inc.’s beta against major indicesJuly 2025 Price Swings & Capital Efficient Trade Techniques - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Is Sight Sciences Inc. stock a value trapJuly 2025 Institutional & Risk Controlled Swing Alerts - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

Should I average down on Sight Sciences Inc. stockJuly 2025 Big Picture & Daily Profit Focused Screening - kpenews.com

Sep 01, 2025
pulisher
Sep 01, 2025

Predicting Sight Sciences Inc. trend using moving averagesQuarterly Portfolio Summary & Intraday High Probability Alerts - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Sight Sciences, Inc. (NASDAQ:SGHT) Q2 2025 Earnings Call Transcript - MSN

Sep 01, 2025
pulisher
Aug 31, 2025

Will Sight Sciences Inc. continue its uptrendJuly 2025 Weekly Recap & Technical Analysis for Trade Confirmation - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Is Sight Sciences Inc. building a consolidation baseGold Moves & Real-Time Chart Breakout Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Quant Tools Rank Sight Sciences Inc. as High Risk High Reward getLinesFromResByArray error: size == 0 - thegnnews.com

Aug 31, 2025
pulisher
Aug 31, 2025

Can swing trading help recover from Sight Sciences Inc. lossesTrade Risk Summary & Stepwise Entry and Exit Trade Signals - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Can volume confirm reversal in Sight Sciences Inc.Jobs Report & Community Verified Watchlist Alerts - Newser

Aug 31, 2025
pulisher
Aug 30, 2025

How high can Sight Sciences Inc. stock goMarket Performance Report & Reliable Breakout Forecasts - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Technical signs of recovery in Sight Sciences Inc.Trade Ideas & AI Driven Stock Reports - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Analyzing recovery setups for Sight Sciences Inc. investorsTrade Volume Summary & Entry Point Confirmation Signals - Newser

Aug 30, 2025

Finanzdaten der Sight Sciences Inc-Aktie (SGHT)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Sight Sciences Inc-Aktie (SGHT) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
HAYDEN JEREMY B.
Chief Legal Officer
Jul 03 '25
Sale
4.17
9,160
38,234
266,321
Bauerlein Alison
Chief Financial Officer
Jul 02 '25
Sale
4.10
19,260
78,927
617,468
Badawi Paul
President and CEO
Jul 01 '25
Sale
4.15
23,637
98,141
5,986,943
Badawi David
Chief Technology Officer
Jul 03 '25
Sale
4.17
5,679
23,704
1,831,025
Link Matthew
Chief Commercial Officer
Jul 02 '25
Sale
4.10
4,889
20,035
832,293
medical_devices STE
$243.39
price up icon 0.38%
$346.47
price up icon 0.86%
medical_devices PHG
$27.73
price up icon 2.14%
$80.76
price up icon 2.33%
$74.12
price up icon 2.40%
medical_devices EW
$80.96
price down icon 0.32%
Kapitalisierung:     |  Volumen (24h):